Litigation Details for CUBIST PHARMACEUTICALS LLC v. CIPLA USA INC. (D.N.J. 2019)
✉ Email this page to a colleague
CUBIST PHARMACEUTICALS LLC v. CIPLA USA INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-05-24 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-10-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Zahid Nisar Quraishi |
| Patents | 9,138,456 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CUBIST PHARMACEUTICALS LLC v. CIPLA USA INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Biologic Drugs cited in CUBIST PHARMACEUTICALS LLC v. CIPLA USA INC.
The biologic drug covered by the patent cited in this case is ⤷ Sign Up .
Details for CUBIST PHARMACEUTICALS LLC v. CIPLA USA INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-05-24 | 1 | Complaint | infringement of United States Patent No. 9,138,456 (the “’456 patent”) under the laws of the United …Letter. COUNT I: INFRINGEMENT OF U.S. PATENT NO. 9,138,456 BY DEFENDANTS 29. Plaintiff… THE PATENT-IN-SUIT 5. On September 22, 2015, the United States Patent and Trademark… the ’456 patent, it would further infringe at least claims 1-2 and 7-11 of the ’456 patent under 35 …of the ’456 patent. 32. Cipla has had knowledge of the ’456 patent since at least | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
